The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Latest Articles
Published online
doi:10.1084/jem.20082468
The Journal of Experimental Medicine
The Rockefeller University Press, 0022-1007 $30.00
© Robert et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3272K)
Right arrow PDF+supp data (4769K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robert, I.
Right arrow Articles by Reina-San-Martin, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robert, I.
Right arrow Articles by Reina-San-Martin, B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

 Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination

Isabelle Robert1, Françoise Dantzer2, and Bernardo Reina-San-Martin1

1 Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Department of Cancer Biology. Institut National de la Santé et de la Recherche Médicale U964-Centre National de la Recherche Scientifique UMR7104, Université de Strasbourg, 67404 Illkirch, France
2 Poly(ADP-ribosyl)ation et Intégrité du Génome, IREBS-FRE3211 Centre National de la Recherche Scientifique, Université de Strasbourg, Ecole Supérieure de Biotechnologie de Strasbourg, 67412 Illkirch, France

CORRESPONDENCE Bernardo Reina-San-Martin:reinab{at}igbmc.fr

Immunoglobulin class switch recombination (CSR) is initiated by DNA breaks triggered by activation-induced cytidine deaminase (AID). These breaks activate DNA damage response proteins to promote appropriate repair and long-range recombination. Aberrant processing of these breaks, however, results in decreased CSR and/or increased frequency of illegitimate recombination between the immunoglobulin heavy chain locus and oncogenes like c-myc. Here, we have examined the contribution of the DNA damage sensors Parp1 and Parp2 in the resolution of AID-induced DNA breaks during CSR. We find that although Parp enzymatic activity is induced in an AID-dependent manner during CSR, neither Parp1 nor Parp2 are required for CSR. We find however, that Parp1 favors repair of switch regions through a microhomology-mediated pathway and that Parp2 actively suppresses IgH/c-myc translocations. Thus, we define Parp1 as facilitating alternative end-joining and Parp2 as a novel translocation suppressor during CSR.

Abbreviations used: AID, activation-induced cytidine deaminase; ATM, ataxia-telangiectasia mutated; CSR, class switch recombination; DSB, double-stranded DNA break; IgH, Ig heavy chain; NHEJ, nonhomologous end-joining pathway; SHM, somatic hypermutation; UNG, uracyl DNA glycosylase.

© 2009 Robert et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search